A Phase 1, Open-label, Randomized, Cross-over Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of a Single Dose of rhPTH(1-84) Administered Subcutaneously in Japanese Healthy Subjects Compared With Matched Non-Hispanic, Caucasian Healthy Adult Subjects and to Assess Dose Proportionality of 3 Doses of rhPTH(1-84) in the Japanese Subjects
Phase of Trial: Phase I
Latest Information Update: 16 Aug 2017
At a glance
- Drugs Parathyroid hormone (Primary)
- Indications Hypoparathyroidism
- Focus Pharmacokinetics
- Sponsors Shire
- 01 Aug 2017 Status changed from recruiting to completed.
- 23 May 2017 New trial record
- 15 May 2017 Status changed from not yet recruiting to recruiting.